BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 24714582)

  • 1. Relationship between continuity of ambulatory care and medication adherence in adult patients with type 2 diabetes in Korea: a longitudinal analysis.
    Hong JS; Kang HC
    Med Care; 2014 May; 52(5):446-53. PubMed ID: 24714582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuity of ambulatory care and health outcomes in adult patients with type 2 diabetes in Korea.
    Hong JS; Kang HC
    Health Policy; 2013 Feb; 109(2):158-65. PubMed ID: 23093021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuity of care, medication adherence, and health care outcomes among patients with newly diagnosed type 2 diabetes: a longitudinal analysis.
    Chen CC; Tseng CH; Cheng SH
    Med Care; 2013 Mar; 51(3):231-7. PubMed ID: 23269110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO; Barner JC; Rascati KL; Strassels SA
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuity of care and changes in medication adherence among patients with newly diagnosed diabetes.
    Chen CC; Cheng SH
    Am J Manag Care; 2016 Feb; 22(2):136-42. PubMed ID: 26885673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better continuity of care reduces costs for diabetic patients.
    Chen CC; Chen SH
    Am J Manag Care; 2011 Jun; 17(6):420-7. PubMed ID: 21756012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does medication adherence lead to lower healthcare expenses for patients with diabetes?
    Cheng SH; Chen CC; Tseng CH
    Am J Manag Care; 2013 Aug; 19(8):662-70. PubMed ID: 24304214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus.
    Cobden D; Lee WC; Balu S; Joshi AV; Pashos CL
    Pharmacotherapy; 2007 Jul; 27(7):948-62. PubMed ID: 17594200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
    Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
    Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective real-world adherence in patients with type 2 diabetes initiating once-daily liraglutide 1.8 mg or twice-daily exenatide 10 μg.
    Malmenäs M; Bouchard JR; Langer J
    Clin Ther; 2013 Jun; 35(6):795-807. PubMed ID: 23642290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in patients with type 2 diabetes: impact on adherence to oral hypoglycemic agents.
    Kalsekar ID; Madhavan SS; Amonkar MM; Makela EH; Scott VG; Douglas SM; Elswick BL
    Ann Pharmacother; 2006 Apr; 40(4):605-11. PubMed ID: 16551768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Ambulatory Medical Care Survey: 2001 summary.
    Cherry DK; Burt CW; Woodwell DA
    Adv Data; 2003 Aug; (337):1-44. PubMed ID: 12924075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients.
    Cheong C; Barner JC; Lawson KA; Johnsrud MT
    Clin Ther; 2008 Oct; 30(10):1893-907. PubMed ID: 19014846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.
    Nau DP; Chao J; Aikens JE
    Res Social Adm Pharm; 2005 Sep; 1(3):378-88. PubMed ID: 17138485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refill adherence to oral antihyperglycaemic drugs in Sweden.
    Haupt D; Weitoft GR; Nilsson JL
    Acta Diabetol; 2009 Sep; 46(3):203-8. PubMed ID: 19023514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization.
    Sun P; Lian J
    Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.